Cullinan Therapeutics reported total assets of $363.79M and total liabilities of $42.03M for the quarter ended Jun 2026, down 30.1% year over year. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.23M | 0.14M | 0.35M | 0.66M | 0.97M | |||||||||||||||||||||
| Assets | ||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 445.40M | 59.77M | 314.90M | 611.00M | 576.00M | 156.15M | 390.70M | 491.80M | 466.40M | 98.43M | 74.23M | 115.02M | 578.10M | 83.00M | 303.80M | 265.50M | 332.60M | 88.33M | 351.90M | 334.50M | ||||||
| Prepaid Assets | 7.79M | 6.10M | 7.46M | 11.85M | 6.12M | 7.18M | 8.33M | 6.44M | 10.28M | 13.12M | 12.71M | 15.30M | 13.96M | 15.69M | 13.95M | 10.43M | 9.64M | 8.86M | 9.52M | 7.44M | ||||||
| Current Assets | 328.84M | 296.56M | 322.31M | 622.84M | 582.08M | 474.47M | 399.03M | 498.24M | 476.71M | 480.19M | 445.72M | 677.80M | 592.04M | 414.67M | 317.77M | 275.91M | 342.24M | 386.76M | 361.41M | 341.97M | ||||||
| Non-Current Assets | ||||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 0.09M | 0.08M | 0.06M | 0.05M | 0.79M | 1.17M | 1.24M | 1.16M | 1.07M | 0.99M | 0.91M | 0.84M | 0.76M | 0.68M | 0.61M | 0.57M | 0.49M | 0.42M | 0.34M | 0.26M | ||||||
| Long-Term Investments | 124.33M | 140.40M | 95.40M | 44.60M | 30.70M | 80.88M | 112.80M | 20.30M | 15.50M | 57.98M | 204.44M | 259.39M | 242.30M | 140.00M | 58.27M | 38.50M | 19.02M | |||||||||
| Long-Term Deferred Tax | 19.57M | |||||||||||||||||||||||||
| Other Non-Current Assets | 0.15M | 0.15M | 0.15M | 0.10M | 0.46M | 0.46M | 0.46M | 0.46M | 0.46M | 0.46M | 0.46M | 0.46M | 0.46M | 0.37M | 0.37M | 0.37M | 0.36M | 0.30M | 0.30M | 0.30M | ||||||
| Non-Current Assets | 124.57M | 140.62M | 115.15M | 44.41M | 35.16M | 86.64M | 115.96M | 23.75M | 18.00M | 3.99M | 3.71M | 3.42M | 61.22M | 207.16M | 261.91M | 244.42M | 141.89M | 61.62M | 41.58M | 21.81M | ||||||
| Assets | 453.40M | 437.19M | 437.46M | 667.25M | 617.24M | 561.12M | 514.99M | 521.98M | 494.71M | 484.18M | 449.43M | 681.22M | 653.25M | 621.82M | 579.68M | 520.33M | 484.13M | 448.37M | 402.98M | 363.79M | ||||||
| Liabilities | ||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||
| Accounts Payables | 2.02M | 3.17M | 6.31M | 3.10M | 1.52M | 2.66M | 2.03M | 2.49M | 0.95M | 2.49M | 3.71M | 1.55M | 2.12M | 1.68M | 3.40M | 2.46M | 1.72M | 0.84M | 2.51M | 3.73M | ||||||
| Payables | 2.02M | 3.17M | 6.31M | 3.10M | 1.52M | 2.66M | 2.03M | 2.49M | 0.95M | 2.49M | 3.71M | 1.55M | 2.12M | 1.68M | 3.40M | 2.46M | 1.72M | 0.84M | 2.51M | 3.73M | ||||||
| Accumulated Expenses | 5.84M | 8.58M | 10.43M | 11.90M | 13.51M | 14.13M | 18.38M | 15.53M | 20.95M | 24.20M | 16.89M | 20.71M | 20.83M | 27.66M | 22.60M | 24.20M | 29.85M | 36.12M | 31.92M | 36.24M | ||||||
| Other Accumulated Expenses | 0.97M | 1.96M | 0.91M | 1.44M | 1.00M | |||||||||||||||||||||
| Current Leases | 0.52M | 0.53M | 0.70M | 1.42M | 1.55M | 1.65M | 1.55M | 1.44M | 1.33M | 1.22M | 1.26M | 1.30M | 1.35M | 1.39M | 1.19M | 0.78M | 0.72M | 0.67M | ||||||||
| Current Taxes | 46.50M | 11.40M | 4.28M | 4.21M | ||||||||||||||||||||||
| Total Current Liabilities | 7.86M | 11.75M | 17.26M | 62.03M | 27.12M | 22.50M | 26.17M | 19.68M | 23.44M | 28.14M | 21.93M | 23.48M | 24.20M | 30.65M | 27.35M | 28.06M | 32.76M | 37.74M | 35.15M | 40.63M | ||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||
| Non-Current Deffered Revenue | 0.07M | 0.07M | ||||||||||||||||||||||||
| Minority Interest | 2.09M | 0.40M | 0.77M | 0.08M | 0.19M | |||||||||||||||||||||
| Operating Leases | 0.74M | 0.60M | 3.99M | 3.59M | 3.17M | 2.73M | 2.45M | 2.15M | 1.84M | 1.52M | 1.19M | 0.85M | 0.49M | 0.12M | 1.90M | 1.66M | 1.41M | |||||||||
| Total Liabilities | 7.93M | 11.81M | 17.99M | 62.63M | 31.11M | 26.09M | 29.34M | 22.41M | 25.89M | 30.29M | 23.77M | 25.00M | 25.39M | 31.50M | 27.84M | 28.18M | 32.76M | 39.64M | 36.81M | 42.03M | ||||||
| Shareholder's Equity | ||||||||||||||||||||||||||
| Common Equity | 445.47M | 425.37M | 419.47M | 604.62M | 586.13M | 535.03M | 485.65M | 499.57M | 468.82M | 453.89M | 425.67M | 656.22M | 627.86M | 590.33M | 551.84M | 492.15M | 451.37M | 408.73M | 366.17M | 321.75M | ||||||
| Liabilities and Shareholders Equity | 453.40M | 437.19M | 437.46M | 667.25M | 617.24M | 561.12M | 514.99M | 521.98M | 494.71M | 484.18M | 449.43M | 681.22M | 653.25M | 621.82M | 579.68M | 520.33M | 484.13M | 448.37M | 402.98M | 363.79M | ||||||
| Retained Earnings | -126.40M | -158.91M | -171.01M | 3.89M | -20.91M | -47.70M | -105.66M | -137.87M | -177.05M | -200.86M | -238.00M | -280.03M | -320.59M | -368.24M | -416.74M | -486.80M | -537.41M | -588.12M | -637.78M | -691.48M | ||||||
| Treasury Shares | 85.60M | 85.60M | 85.60M | 85.60M | 85.60M | 85.60M | 85.60M | 85.60M | 85.60M | 85.60M | 85.60M |